Rep John Eplee, MD Speaks at Public Hearing on School Immunization Requirements

Immunize Kansas Coalition

The public hearing for the proposed regulation changes regarding vaccination for school entry was last week. Thank you to all who provided comments.

Thank you to  Representative John Eplee, MD, FAAFP, who presented his support for meningococcal immmunization and Hepatitis A immunizations as a school requirement last week at the hearing.

Full information is available regarding:  Proposed Regulation, Economic Impact Statement


CDC Immunizations Information Systems Vaccine Code Updates

National Center for Immunization and Respiratory Diseases

The following Registry ISS codes have been updated and available. Please share with your office staff.

Read more


CDC Resources Offer Tools on Vaccine Administration, Safety, and More


CDC has developed a comprehensive web section of immunization resources to help support healthcare professionals. CDC’s Resources for Health Care Providers web section offers a variety of immunization resources which are described below.

Be sure to check out the information and printable materials available at CDC’s Resources for Health Care Providers web section.

Public Hearing for School Immunization Requirement Proposed Changes is June 27

Immunize Kansas Coalition

The public hearing for the proposed regulation changes regarding vaccination for school entry, has been scheduled:

Thursday, June 27 | 10:00 a.m.
Curtis State Office Building, Room 530
1000 SW Jackson, Topeka, KS

For anyone wishing to submit comments:

  • Oral: “During the hearing, all interested parties will be given a reasonable opportunity to present their views orally on the proposed regulation. In order to give each individual an opportunity to present their views, it may be necessary for the hearing office to request that each presenter limit an oral presentation to an appropriate time frame.”
  • Written:  “All interested parties may submit written comments prior to 5:00 p.m. on the day of the hearing to Phil Griffin” by email, fax, or mail.

Full information is available regarding: Notice of Hearing, Proposed Regulation, Economic Impact Statement

Kansas Immunization Program -Knowledge Injection Series is May 16

University of Kansas Medical Center

Register online for this no cost webinar!

KIP-KIS Session:
We’re Not There Yet…Strategies Toward Improving HPV Vaccination in Kansas by Gretchen Homan, MD
Thursday, May 16, 2019
Noon – 1:00 p.m.

At the conclusion of this session participants should be able to:

  1. Review background information on HPV disease and vaccine.
  2. Discuss vaccination strategies and counseling.
  3. Explore pro-vaccination culture.

For additional assistance with registration, call the KU Area Health Education Center at (620) 235-4040.


Celebrate National Infant Immunization Week’s 25th Anniversary


This week marks the 25th anniversary of National Infant Immunization Week (NIIW) – April 27–May 4, 2019.

Here are some ideas for ways that your practice can celebrate NIIW this year:

By making NIIW an event for your entire practice, you can raise awareness about the importance of immunization for protecting children in your community and be a strong voice in support of CDC’s recommended immunization schedule.


KIP-KIS Session: Vaccine Safety – April 18


Make plans to attend this Thursday!

Knowledge Injection Series (KIP-KIS) Session: Vaccine Safety

Thursday, April 18 | Noon to 1:00 p.m.

Presenter: Daniel Salmon, PhD, MPH, Institute of Vaccine Safety Director John Hopkins Bloomberg School of Public Health

Learning Objectives:

  • Discuss the importance of vaccine safety in the context of mature immunization programs.
  • Identify the strengths and limitations of the many processes to ensure vaccines are very safe throughout a product lifecycle.

Continuing education credit will be available.

Read more

Measles Outbreak in 15 States


From January 1 to March 28, 2019, 387** individual cases of measles have been confirmed in 15 states.  This is the second-greatest number of cases reported in the U.S. since measles was eliminated in 2000. View cases and outbreaks.

The states that have reported cases to CDC are Arizona, California, Colorado, Connecticut, Georgia, Illinois, Kentucky, Michigan, Missouri, New Hampshire, New Jersey, New York, Oregon, Texas, and Washington.

The CDC recommends the following:

  • Routine childhood immunization for MMR vaccine starting with the first dose at 12 through 15 months of age, and the second dose at 4 through 6 years of age or at least 28 days following the first dose.
  • Students at post-high school educational institutions without evidence of measles immunity need two doses of MMR vaccine, with the second dose administered no earlier than 28 days after the first dose.
  • Adults: People who are born during or after 1957 who do not have evidence of immunity against measles should get at least one dose of MMR vaccine.

Mark Your Calendars for National Infant Immunization Week


This year marks the 25th anniversary of National Infant Immunization Week (NIIW). From April 27–May 4, 2019, NIIW will highlight the importance of protecting infants from vaccine-preventable diseases and will celebrate the achievements of immunization programs in promoting healthy communities throughout the United States. Learn more about National Infant Immunization Week.

CDC publishes interim estimates of the 2018–19 influenza vaccine effectiveness

IAC Express

CDC published Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness—United States, February 2019 in the February 15 issue of MMWR (pages 135–139). A summary made available to the press is reprinted below.

CDC recommends yearly influenza vaccination for children at least 6 months old and adults. Early estimates indicate that influenza vaccines have reduced the risk of medically attended influenza-related illness by almost half (47%) in vaccinated people so far this season. Vaccination reduced the rate of illness caused by the predominant influenza H1N1 virus by about 46 percent among patients of all ages, and by about 62 percent among children 6 months through 17 years of age. Vaccination provided similar protection to that seen in previous H1N1 seasons in children and in adults younger than age 50. For these estimates, 3,254 children and adults with acute respiratory illness were enrolled from November 23, 2018 to February 2, 2019 at five study sites with outpatient medical facilities in the United States.

Influenza activity continues to increase in the U.S.  with six additional pediatric deaths from influenza reported, for a total of 34 as of February 9. Please continue to vaccinate all your patients six months of age and older.